Bank of America’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-73,600
Closed -$564K 7438
2019
Q2
$564K Buy
+73,600
New +$396K ﹤0.01% 4975

Other funds holding PGEN

Bank of America's PGEN Position: Q1 2026 in Review

Bank of America reduced its Precigen (PGEN) stake by 33% in Q1 2026, selling an estimated $2.94M and leaving 1,471,279 shares worth $5.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3368.

Bank of America first reported a position in PGEN in Q3 2013 and has held it in 51 quarters since. The position peaked at $15.7M in Q2 2015. 206 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Bank of America held 1,471,279 shares of Precigen worth $5.69M as of Q1 2026.
  • Bank of America sold 717,327 Precigen shares in Q1 2026, an estimated $2.94M.
  • Precigen made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3368 holding.
  • Bank of America first reported a position in Precigen in Q3 2013 and has held it in 51 quarters since.
  • Bank of America's Precigen position peaked at $15.7M in Q2 2015.
  • 206 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.